Zai Lab Ltd (ZLAB)

NASDAQ
150.06
+0.61(+0.41%)
  • Volume:
    459,754
  • Bid/Ask:
    145.00/176.77
  • Day's Range:
    142.50 - 152.06

ZLAB Overview

Prev. Close
149.45
Day's Range
142.5 - 152.06
Revenue
48.96M
Open
143.39
52 wk Range
62.89 - 193.54
EPS
-3.46
Volume
459,754
Market Cap
13.83B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
523,969
P/E Ratio
-
Beta
1.16
1-Year Change
114.43%
Shares Outstanding
87,811,026
Next Earnings Date
Sep 02, 2021
What is your sentiment on Zai Lab Ltd?
or
Market is currently closed. Voting is open during market hours.

Zai Lab Ltd News

  • Zai Lab Earnings Miss, Revenue Beats In Q1
    • ByInvesting.com-

    Investing.com - Zai Lab (NASDAQ:ZLAB) reported on Monday first quarter earnings that missed analysts' forecasts and revenue that topped expectations. Zai Lab announced earnings...

  • Zai Lab EPS misses by $1.78, beats on revenue
    • BySeeking Alpha-

    Zai Lab (ZLAB): Q1 GAAP EPS of -$2.64 misses by $1.78.Revenue of $20.1M (+145.1% Y/Y) beats by $2.44M.Cash and cash equivalents, short-term investments and restricted cash of...

Zai Lab Ltd Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesNeutralStrong SellSellSellBuy
Technical IndicatorsBuyNeutralSellStrong SellStrong Buy
SummaryNeutralSellSellStrong SellStrong Buy

Zai Lab Ltd Company Profile

Zai Lab Ltd Company Profile

Employees
692

Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.

Read More
  • time to ROCK N ROLL
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.